Dallas, Texas (PRWEB) July 20, 2014
The population of Mexico was approximately 118.8 million in 2013, and is estimated to grow at a Compound Annual Growth Rate (CAGR) of 1.8%, to approximately 128.6 million in 2020. This is due to a positive balance between the birth and mortality rates. The government has been successful in implementing the steps necessary for achieving universal healthcare coverage, such as reforms in the System of Social Protection in Health (Sistema de Protección Social en Salud). The value of the Mexican pharmaceutical market amounted to $14 billion, in 2013, and is expected to increase at a CAGR of 7% to reach approximately $22.5 billion in 2020. The medical device market was worth $3.6 billion in 2013 and is projected to reach $5.4 billion in 2020, at a CAGR of 6.1%. These positive growth trends can be attributed primarily to government initiatives in the public healthcare sector and an improved and updated regulatory environment.
Complete Report Available @ http://www.marketoptimizer.org/countryfocus-healthcare-regulatory-and-reimbursement-landscape-mexico.html .
“CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Mexico." The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Mexico. It identifies the key trends in the country’s healthcare market and provides insights into its healthcare infrastructure and demographic, regulatory and reimbursement landscape. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.
The report provides information on the healthcare, regulatory and reimbursement landscape in Mexico, and includes -
Order a purchase copy of this report @ http://www.marketoptimizer.org/contacts/purchase?rname=8465 .
Reasons to buy
This report will enhance your decision-making capability by allowing you to -
Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2.1 GlobalData Report Guidance
3 Overview of the Pharmaceutical and Medical Device Markets
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Pharmaceutical Exports and Imports
3.1.3 Supply Channels
3.1.4 Market Segments
3.1.5 Major Disease Areas
3.1.6 Major Players
3.2 Medical Device Market
3.2.1 Market Overview
3.2.2 Overview of Top Five Segments
3.2.3 Diagnostics Market
3.2.4 Major Players
3.3 Market Drivers and Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.1.1 Overview of Healthcare system
4.1.2 Reimbursement Process
4.1.3 Overview of Insurance Providers
4.1.4 Patient Share in Healthcare Spending
4.1.5 Price Trends in the Healthcare Sector
4.1.6 Pricing Policies
4.2 Regulatory Landscape
4.2.1 Overview of Regulatory Agencies
4.2.2 Market Authorization Procedure for Pharmaceutical Products
4.2.3 New Medical Device Approval Process
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
4.2.5 Exports and Imports
4.2.6 Intellectual Property Rights
4.2.7 Clinical Trial Regulations
4.2.8 Pharmaceutical Advertising Regulations
4.2.9 Pharmacy Regulations
4.2.10 Labeling and Packaging Regulations
5 Country Analysis
5.1 Political Environment
5.2 Economic Landscape
5.3 Economic Indicators
5.5 Healthcare Infrastructure
5.6 Healthcare Expenditure
5.7 Trade Associations
5.8 Trade Fairs
6 Opportunities and Challenges
Explore more reports on Healthcare industry at http://www.marketoptimizer.org/category/life-sciences/healthcare.
MarketOptimizer.org is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Read the full story at http://www.prweb.com/releases/mexico-pharmaceutical/market-analysis-to-2020/prweb12029557.htm.
Copyright©2014 Vocus, Inc.
All rights reserved